Hedyeh Ebrahimi, M.D, M.P.H. (IMAGE)
Caption
"While not yet part of standard cancer treatment protocols, microbiome modulation is a promising area of research with the potential to enhance the efficacy of cancer therapies, particularly immunotherapies. Current applications are primarily within clinical trials, but the growing body of evidence suggests that microbiome-based interventions may soon become a valuable component of cancer treatment strategies,” said Hedyeh Ebrahimi, M.D, M.P.H., City of Hope postdoctoral medical oncology fellow and first author of the Nature Medicine study.
Credit
City of Hope
Usage Restrictions
Please use credit information
License
Original content